These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1657632)

  • 41. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma.
    Gómez FP; Roca J; Barberà JA; Chung KF; Peinado VI; Rodriguez-Roisin R
    Eur Respir J; 1998 Apr; 11(4):835-9. PubMed ID: 9623685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tracheobronchial clearance in patients with bilateral diaphragmatic weakness.
    Mier A; Laroche C; Agnew JE; Vora H; Clarke SW; Green M; Pavia D
    Am Rev Respir Dis; 1990 Sep; 142(3):545-8. PubMed ID: 2389906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man.
    Chung KF; Minette P; McCusker M; Barnes PJ
    J Allergy Clin Immunol; 1988 Jun; 81(6):1192-8. PubMed ID: 3288683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of platelet activating factor on mucociliary clearance of the eustachian tube.
    Ganbo T; Hisamatsu K; Kikushima K; Nakajima M; Inoue H; Murakami Y
    Ann Otol Rhinol Laryngol; 1996 Feb; 105(2):140-5. PubMed ID: 8659935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibronectin levels in plasma after platelet-activating factor inhalation.
    Nabe M; Miyagawa H; Hopp RJ; Agrawal DK; Bewtra AK; Townley RG
    Int Arch Allergy Appl Immunol; 1990; 91(2):113-7. PubMed ID: 2341190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of platelet-activating factor on rat airways.
    Misawa M; Takata T
    Jpn J Pharmacol; 1988 Sep; 48(1):7-13. PubMed ID: 3199608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of platelet activating factor on the tubotympanic mucosa and inner ear in the guinea pig.
    Ohno Y; Ohashi Y; Sugiura Y; Okamoto H; Nakai Y
    Ann Otol Rhinol Laryngol; 1998 Oct; 107(10 Pt 1):876-84. PubMed ID: 9794619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of adrenergic stimulation on clearance from small ciliated airways in healthy subjects.
    Svartengren K; Philipson K; Svartengren M; Camner P
    Exp Lung Res; 1998; 24(2):149-58. PubMed ID: 9555573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects.
    Black PN; Fuller RW; Taylor GW; Barnes PJ; Dollery CT
    Thorax; 1989 Jun; 44(6):491-5. PubMed ID: 2548300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for platelet-activating factor secretion during immune activation in dogs.
    Munoz NM; Stimler-Gerard NP; Mack MM; Tutins C; Blake JS; Kelly E; Murphy TM; Leff AR
    J Appl Physiol (1985); 1989 Apr; 66(4):1860-6. PubMed ID: 2732178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term clearance from small airways decreases with age.
    Svartengren M; Falk R; Philipson K
    Eur Respir J; 2005 Oct; 26(4):609-15. PubMed ID: 16204590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of inhaled platelet activating factor on bronchial responsiveness in patients with symptomatic and asymptomatic pulmonary embolism.
    Ruiz J; Monreal M; Sala H; Roncalés J; Fiz JA; Monsó E; Morera J
    Chest; 1992 Sep; 102(3):819-23. PubMed ID: 1516409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes.
    Michalis LK; Tambaki AP; Katsouras CS; Goudevenos JA; Kolettis T; Adamides K; Tselepis AD; Sideris DA
    Curr Med Res Opin; 2002; 18(2):108-12. PubMed ID: 12017208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of platelet activating factor on nasal hypersensitivity.
    Andersson M; Pipkorn U
    Eur J Clin Pharmacol; 1988; 35(3):231-5. PubMed ID: 3181276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Leukotrienes do not modify the effects of PAF on human platelet aggregation.
    Filep J; Földes-Filep E
    Thromb Res; 1987 Mar; 45(6):865-70. PubMed ID: 3035743
    [No Abstract]   [Full Text] [Related]  

  • 56. Late appearance of phospholipid platelet-activating factor and leukotriene B4 in human skin after repeated antigen challenge.
    Shalit M; Valone FH; Atkins PC; Ratnoff WD; Goetzl EJ; Zweiman B
    J Allergy Clin Immunol; 1989 Mar; 83(3):691-6. PubMed ID: 2538500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet-activating factor inhibits ciliary beat frequency of human bronchial epithelial cells.
    Klettke U; Luck W; Wahn U; Niggemann B
    Allergy Asthma Proc; 1999; 20(2):115-8. PubMed ID: 10209689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Airway and pulmonary tissue responses to platelet-activating factor in rats.
    Garcia ML; Paiva PS; Dolhnikoff M; Jancar S; Saldiva PH; Martins MA
    Exp Lung Res; 1994; 20(3):169-84. PubMed ID: 7925137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of leukotrienes and platelet activating factor on mucociliary activity in the rabbit maxillary sinus.
    Dolata J; Lindberg S; Mercke U
    Acta Otolaryngol; 1990; 109(1-2):149-54. PubMed ID: 2309553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mucosal dysfunction and damage induced by platelet activating factor (PAF).
    Ganbo T; Hisamatsu K
    Acta Otolaryngol; 1990; 110(5-6):427-36. PubMed ID: 2284918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.